| Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and Other Disorders 2007 Edition Contributor(s): Azziz, Ricardo (Editor) |
|
 |
ISBN: 1588296636 ISBN-13: 9781588296634 Publisher: Humana OUR PRICE: $208.99 Product Type: Hardcover - Other Formats Published: September 2006 Annotation: This thoroughly revised and comprehensive edition of a highly praised classic, Androgen Excess Disorders in Women covers the growing importance of polycystic ovary syndrome (PCOS) as the most prevalent androgen excess disorder in women. This volume addresses the latest research findings on the etiology, pathophysiology, clinical manifestations, genetics, and consequences of androgen excess disorders in women, including PCOS, nonclassic adrenal hyperplasia, androgen-secreting tumors, severe insulin-resistant hyperandrogenic syndromes, and rarer causes of androgen excess and hirsutism. Full consideration is given to the long-term consequences of androgen excess and PCOS, including endometrial hyperplasia and carcinoma, infertility, cardiovascular and lipoprotein abnormalities, osteoporosis, obesity and glucose intolerance, and psychosocial problems. In addition, detailed information on the methods now available for diagnosis and treatment of these disorders are extensively reviewed. Cutting-edge and timely, the second edition of Androgen Excess Disorders in Women: Polycystic Ovary Syndrome and Other Disorders serves as an indispensable guide and resource for clinicians and researchers alike in the care and study of women with androgen excess disorders. |
| Additional Information |
| BISAC Categories: - Medical | Gynecology & Obstetrics - Medical | Endocrinology & Metabolism |
| Dewey: 618.1 |
| LCCN: 2006003453 |
| Series: Contemporary Endocrinology (Humana Press) |
| Physical Information: 1.08" H x 7.22" W x 10.14" (2.21 lbs) 488 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: The field of androgen excess disorders has advanced substantially since the original publication of this book. The Androgen Excess Society (AES) was founded to bring together investigators in the field. A better understanding of the screening, progression, and molecular genetics of nonclassic adrenal hyperplasia (NCAH) has improved the clinical care and diagnostic accuracy of these patients. New criteria for the diagnosis of the polycystic ovary syndrome (PCOS) were proposed in Rotterdam, criteria that have resulted in controversy and, hopefully, initiation of new studies. The association of insulin resistance with PCOS has been strengthened, and the role of metformin in tre- ing the infertility of the PCOS has been validated. Risks for diabetes and, more cont- versially, cardiovascular disease in women with PCOS have received substantial investigation. Our understanding of the epidemiology and economic impact of these disorders has expanded, emphasizing their critical importance. These are but a few highlights of how the terrain has changed in a relatively brief period of time. In keeping with these advances, the title of this book has been revised to reflect the growing importance of PCOS as the most prevalent androgen excess disorder in women, and arguably, as the one that might have the most serious adverse consequences for general health. There are fewer chapters to provide a more focused elucidation of the area. Several chapters were penned by new (and young) authors who are conducting cutting-edge research in the field. |